Page 5 - One Partnering News Today

/PRNewswire/ -- AUM LifeTech, Inc., a preclinical stage biotechnology company, announced today that it has been selected by the National Institutes of Health...

RALEIGH, NC / ACCESSWIRE / June 9, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that John Temperato, CEO

VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company…

ADELAIDE, AUS, June 4, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their

Avance Clinicals USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities

BIO Digital lands at a time of ‘unprecedented industry collaboration’ By Jenni Spinner The online pharma event will address the COVID-19 pandemic’s impact on the industry (and vice versa) and innovation in the face of formidable challenges. While COVID-19’s grip on the globe seems to be gradually waning, organizers of pharma events are still judging on the side of caution and keeping most events virtual for the time...

BIO DIGITAL 2021 To Feature WHOs WHO IN PUBLIC HEALTH iCrowd Newswire Former CNN anchor Albert Bourla, Richard Haass, Janet Woodcock, and a host of industry leaders WASHINGTON (May 3, 2021) -Looking back on a year of unprecedented industry collaboration, discovery and achievement, the Biotechnology Innovation Organization (BIO) has begun announcing the featured speakers at this years BIO Digital, which runs June 10-11(pre-event) and 14-18 (live event), 2021.Attendees at this years BIO Digital...

RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences Glen Rock, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPID) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that the Company’s senior management will participate in two virtual investor confe...

Citrine Medicine to Participate at Three Upcoming Biotech Industry Conferences News provided by Share this article Share this article CAMBRIDGE, Mass. and SHANGHAI, China, Jan. 8, 2021 /PRNewswire/ -- Citrine Medicine, a China-based rare disease therapeutics company, today announced that company management will participate at three conferences in January, including the 39 th Annual J.P. Morgan Healthcare Conference. Conference details are as follows: 39th Annual J.P. Morgan Healthcare Con...

Good Day BIO December 21, 2020 In distressing times, we get by with a little help from our friends, as the song goes. And as we’ve seen this year, collaboration and partnership are keys to getting through times of uncertainty, economic hardship, and solving enormous challenges—from ending a global pandemic to eradicating systemic racism and inequity in society. In the last quarter of 2020, BIO welcomed 52 new members, for a grand total of 150 members this year—a recognition o...